Age-Dependent Reduction in Neutralization against Alpha and Beta Variants of BNT162b2 SARS-CoV-2 Vaccine-Induced Immunity
BNT162b2 SARS-CoV-2 백신 유도 면역의 알파 및 베타 변이체에 대한 중화의 연령 의존적 감소
Research Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
age
All participants
anti-RBD
antibody
antibody level
antibody levels
Antibody test
Antigen
basic
Beta
binding domain
BNT162b2
BNT162b2 vaccine
Clinical characteristics
collected
Coronavirus-2
correlated
Cutoff
decrease
female
groups
Health care
Health care worker
health care workers
heterogeneity
high risk
higher risk
Humoral immunity
Immunity
include
individual
Infection
interquartile range
introduced
IQR
median
mRNA vaccine
mRNA vaccines
neutralization
Neutralizing
Neutralizing activity
Neutralizing antibodies
of BNT162b2
Older age
participant
Patient
patient age
positive
Pseudotyped virus
questionnaire
Questionnaires
Randomly
Receptor-binding domain
reduction
respiratory
SARS-CoV-2
SARS-COV-2 infection
second dose
selected
sera
serum dilution
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
Spike protein
Toyama
U/mL
university
vaccination
variant
variants
Viral
viral variant
Viral variants
virus
viruses
was obtained
were measured
wild type
wild-type
wild-type SARS-CoV-2
wild-type virus
[DOI] 10.1128/Spectrum.00561-21 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1128/Spectrum.00561-21 PMC 바로가기 [Article Type] Research Article